| 注册
首页|期刊导航|中国药业|哌拉西林他唑巴坦钠致药物热30例临床分析

哌拉西林他唑巴坦钠致药物热30例临床分析

谢颖 赵宏 龙恩武

中国药业Issue(13):49-51,3.
中国药业Issue(13):49-51,3.

哌拉西林他唑巴坦钠致药物热30例临床分析

Clinical Analysis of Drug Fever Induced by Piperacillin-Tazobactam

谢颖 1赵宏 2龙恩武3

作者信息

  • 1. 四川省第四人民医院临床药学室,四川 成都 610016
  • 2. 中国人民解放军海军机关门诊部,北京 100841
  • 3. 四川省医学科学院·四川省人民医院药学部,四川 成都 610072
  • 折叠

摘要

Abstract

Objective To retrospectively analyze the clinical manifestations, influencing factors of drug fever induced by piperacillin-tazobactam to provide reference for timely and accurately judging drug fever and avoiding excessive, combination or blindly upgrade use of antibacterial drugs during anti-infective treatment process. Methods Totally 30 cases of piperacillin-tazobactam induced drug fever collected in these 3 hospitals from September 2013 to September 2014 were performed the retrospectively statistical analysis on the medication situation, clinical manifestaions, laboratory detection and treatment modes. Results The majority of piperacillin-tazobactam in-duced drug fever occurred on 7-14 d of consecutive medication, the unit cumulative amount was generally between 1. 3- 2. 7g/kg. All patients had a fever during infusion or within some hours after infusion, and most of them had a hyperpyrexia of 38. 5-40 ℃, in which most patients had normal blood leukocytes and neutrophils and normal or mildly elevated CRP, and eosinophils in some pa-tients were mildly increased;some patients were accompanied by chills, shivering, fatigue, most patients had no other obvious uncomfort-able symptoms. The temperature of the patients would drop to the normal level after withdrawal drug within 24-48 h. In generally clin-icians had little understanding and pay attention to drug-fever, which was not conducive to the correct diagnosis of drug fever. Conclusion Piperacillin-tazobactam induced drug fever has no specific diagnostic criteria, but analyzing the fever time, medica-tion time and unit cumulative amount of drug, and combining with the comprehensive consideration of blood routine, CRP and other lab-oratory indexes can provide beneficial reference for judging drug fever. Clinicians should pay attention to the comprehensive judgment and screening the possibility of drug fever for the patients with infectious symptoms improvement by piperacillin-tazobactam anti-in-fective therapy appearing fever again. Clinical pharmacists should make full use of the professional advantages, and play a positive role in assisting clinicians in the diagnosis of drug fever and promoting rational drug use in clinic.

关键词

哌拉西林他唑巴坦钠/药物热/临床分析

Key words

piperacillin-tazobactam/drug fever/clinical analysis

分类

医药卫生

引用本文复制引用

谢颖,赵宏,龙恩武..哌拉西林他唑巴坦钠致药物热30例临床分析[J].中国药业,2015,(13):49-51,3.

中国药业

1006-4931

访问量0
|
下载量0
段落导航相关论文